The goal of the J. Bradley Randleman Lab is to develop novel techniques to measure in vivo corneal biomechanics properties to revolutionize the identification and management of corneal ectatic disorders such as keratoconus and to advance the state of refractive surgery by individualizing patient treatments based on their biomechanical profiles.
Dr. Randleman’s team uses motion Brillouin microscopy to evaluate the impact of various treatments on corneal biomechanics in humans in laboratory models.
James (Bradley) Randleman, MD, is a Professor of Ophthalmology at Cleveland Clinic's Cole Eye Institute. He was previously Professor of Ophthalmology at the Keck School of Medicine of USC and Director of the Cornea & Refractive Surgery Service at the USC Roski Eye Institute in Los Angeles, California and the Hughes Professor of Ophthalmology at Emory University and Director of the Cornea Section at the Emory Eye Center.
A widely respected cornea specialist, his areas of expertise include: corneal and intraocular refractive surgical procedures including LASIK and premium laser-assisted cataract and IOL surgery, complicated cataract surgery, and the management of corneal ectatic disorders. His primary research focuses on identification and management of corneal ectatic diseases including keratoconus and postoperative ectasia after LASIK, and the avoidance, diagnosis, and management of refractive surgical complications. He was awarded multiple grants, including an R01 from the NIH to evaluate corneal biomechanical analysis using Brillouin Microscopy.
Dr. Randleman received his BA degree from Columbia College at Columbia University in New York City, his M.D. degree from Texas Tech University School of Medicine in Lubbock, Texas, where he was elected to the Alpha Omega Alpha medical honor society in his junior year, followed by his Ophthalmology residency at Emory University in Atlanta, Georgia. Dr. Randleman joined the Emory faculty and served as Assistant Residency Director for two years while also completing a fellowship in Cornea/External Disease, and Refractive Surgery at Emory University. He served as Director of the Emory Corneal Fellowship program until taking over as Director of the Cornea Service in 2010 and was named the Hughes Professor of Ophthalmology in 2016.
Dr. Randleman has been awarded the Claus Dohlman Fellow Award, the inaugural Binkhorst Young Ophthalmologist Award from the American Society of Cataract and Refractive Surgery, the Kritzinger Memorial Award, Founder’s Award, and the Inaugural Recognition Award from the International Society of Refractive Surgery, and the Secretariat Award, Achievement Award, and Senior Achievement Award from the American Academy of Ophthalmology.
Dr. Randleman has served as Editor-in-Chief for the Journal of Refractive Surgery since 2011. He has authored more than 150 peer-reviewed publications in leading ophthalmology journals in addition to 40 book chapters on refractive surgery evaluation, corneal cross-linking, and management of complications with IOLs, and has authored four textbooks, Collagen Cross-Linking and Corneal Cross-Linking 2nd Edition, which he co-edited on Farhad Hafezi, MD, PhD, Refractive Surgery: An Interactive Case-Based Approach, and Intraocular Lens Surgery: Selection, Complications, and Complex Cases.
Appointed
2019
Fellowship - Emory Eye Clinic
Cornea External Disease and Refractive Surgery
Atlanta, GA USA
2004
Residency - Emory Eye Clinic
Ophthalmology
Atlanta, GA USA
2002
Internship - Atlanta Medical Center
Transitional Year Internship
Atlanta, GA USA
1999
Medical Education - Texas Tech University School of Medicine
Lubbock, TX USA
1998
Graduate School - Sam Houston State University
Graduate Studies in Biology
Huntsville, TX USA
1994
Undergraduate - Columbia University
1992
View more awards and honors on Dr. Randleman's Cleveland Clinic profile.
The goal of the Randleman Lab is to develop novel techniques to measure in vivo corneal biomechanics properties to revolutionize the identification and management of corneal ectatic disorders such as keratoconus and to advance the state of refractive surgery by individualizing patient treatments based on their biomechanical profiles.
Dr. Randleman’s team uses motion Brillouin microscopy to evaluate the impact of various treatments on corneal biomechanics in humans in laboratory models.
View publications for J. Bradley Randleman, MD
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Our education and training programs offer hands-on experience at one of the nationʼs top hospitals. Travel, publish in high impact journals and collaborate with investigators to solve real-world biomedical research questions.
Learn More